Open AccessReversal of Chemotherapy Resistance to Cisplatin in NSCLC by miRNA-195-5p via Targeting the FGF2 Gene
Author(s) -
Hao Wang,
Zhilin Sui,
Xianxian Wu,
Peng Tang,
Hongdian Zhang,
Zhentao Yu
Publication year - 2021
Publication title -
pharmacogenomics and personalized medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.845
H-Index - 28
ISSN - 1178-7066
DOI - 10.2147/pgpm.s302755
Subject(s) - cisplatin , microrna , cancer research , a549 cell , medicine , lung cancer , chemotherapy , cell growth , cell , reporter gene , oncology , gene , gene expression , biology , biochemistry
To explore the mechanism of miR-195-5p in the pathogenesis non-small cell lung cancer (NSCLC) and cisplatin resistance.